Please be informed, that the CDRR is soliciting for comments from the concerned stakeholders on the draft FDA Circular entitled: Interim Guidelines for the Issuance of Current Good Manufacturing Practice (cGMP) Clearance to Foreign Drug Manufacturers
Comments may be submitted by email to: [email protected] not later than 10 June 2020 (Wednesday) at 3:00PM using the following format:
Name of Company/Organization: | ||
Contact information | ||
Telephone number: | Email address: | |
Section | Comments | Input/Recommendation/ Suggested text (if any) |
In sending your comments, please use the subject: [Comments] Interim Guidelines for FcGMP Clearance
Thank you.
Attachment:->Announcement Interim Guidelines for the Issuance of Foreign cGMP Clearance
Attachment:->Draft on Interim Guidelines for the Issuance of Foreign cGMP Clearance